Co-Authors
This is a "connection" page, showing publications co-authored by Gheyath Nasrallah and Duaa Al-Sadeq.
Connection Strength
2.347
-
The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review. Int J Infect Dis. 2020 Sep; 98:372-380.
Score: 0.890
-
Effect of multiple freeze-thaw cycles on the detection of anti-SARS-CoV-2 IgG antibodies. J Med Microbiol. 2021 Aug; 70(8).
Score: 0.240
-
Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays. Front Biosci (Landmark Ed). 2021 07 30; 26(7):198-206.
Score: 0.240
-
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population. Sci Rep. 2021 06 04; 11(1):11837.
Score: 0.237
-
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals. Microorganisms. 2021 Jan 25; 9(2).
Score: 0.231
-
Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2021 Jan; 102:181-187.
Score: 0.228
-
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses. 2020 05 26; 12(6).
Score: 0.221
-
Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above. BMC Infect Dis. 2021 Jul 05; 21(1):645.
Score: 0.060